Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.

scientific article

Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.1500541
P932PMC publication ID4744543
P698PubMed publication ID26755821
P5875ResearchGate publication ID290379235

P50authorFernando MacianQ30419998
Thomas J QuinnQ45310205
Ari PartanenQ45909988
Sanmay BandyopadhyayQ96196836
Indranil BasuQ96196837
P2093author name stringLisa Scandiuzzi
Wolfgang A Tomé
Chandan Guha
P2860cites workThe safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western populationQ24651013
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaQ24679736
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionQ28131654
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseQ28204166
Enhancement of antitumor immunity by CTLA-4 blockadeQ28275730
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalQ29547865
Immunosuppressive strategies that are mediated by tumor cellsQ29636247
Low-pressure pulsed focused ultrasound with microbubbles promotes an anticancer immunological responseQ30459141
Current and Future Clinical Applications of High-Intensity Focused Ultrasound (HIFU) for Pancreatic CancerQ30478607
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigenQ40333817
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillanceQ40351779
Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunityQ40702024
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.Q40773099
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptorQ41429389
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsQ41672999
The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cellsQ42218721
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathwayQ44539124
A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functionsQ44903259
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilegeQ47860342
High-intensity focused ultrasound in the treatment of solid tumoursQ50250147
The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells.Q51987808
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.Q52936850
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing HostQ57054792
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70Q72432600
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cellsQ73482874
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanomaQ73850975
Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivoQ73932751
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progressionQ74330354
Minimal recruitment and activation of dendritic cells within renal cell carcinomaQ74418862
Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigensQ75207773
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responsesQ77715977
Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs.Q30501320
Investigation of HIFU-induced anti-tumor immunity in a murine tumor modelQ30502120
Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell toleranceQ30504684
Overcoming immune tolerance to cancer by heat shock protein vaccinesQ33337943
Immunogenic and tolerogenic cell deathQ33639097
Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responsesQ34115645
Transcriptional mechanisms underlying lymphocyte tolerance.Q34135663
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergyQ34575119
Transcriptional complexes formed by NFAT dimers regulate the induction of T cell toleranceQ34967371
A mouse tumor-specific transplantation antigen is a heat shock-related proteinQ35603985
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experienceQ35670885
Induction of antigen-specific T cell anergy: An early event in the course of tumor progressionQ35798927
CD91-dependent programming of T-helper cell responses following heat shock protein immunizationQ35973873
Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergyQ36041455
NFAT1 supports tumor-induced anergy of CD4(+) T cellsQ36243594
Heat shock protein 70-associated peptides elicit specific cancer immunityQ36362368
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunityQ36367825
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.Q36371632
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompQ36375152
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cellsQ36399686
Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivoQ36409007
CD40 ligation reverses T cell tolerance in acute myeloid leukemiaQ36793408
Indoleamine 2,3-dioxygenase and tumor-induced toleranceQ36809762
Altered macrophage differentiation and immune dysfunction in tumor developmentQ36809767
Host antitumour immune responses to HIFU ablationQ36853082
Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenicQ36931431
IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genesQ37153986
Immune therapy for cancerQ37324793
Costimulatory and coinhibitory receptors in anti-tumor immunityQ37474920
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironmentQ38098365
Induction and stability of the anergic phenotype in T cellsQ38161200
Egr-2 and Egr-3 are negative regulators of T cell activation.Q38327900
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesionsQ38784095
Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages.Q40005411
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectevasion of host immune responseQ1660157
focused ultrasoundQ50333304
P304page(s)1964-1976
P577publication date2016-01-11
P1433published inJournal of ImmunologyQ3521441
P1476titleLow-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.
P478volume196

Reverse relations

cites work (P2860)
Q42973443Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities
Q64102482Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
Q90169619Focused ultrasound activates voltage-gated calcium channels through depolarizing TRPC1 sodium currents in kidney and skeletal muscle
Q42690545Immuno-thermal ablations - boosting the anticancer immune response
Q50324081Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults
Q49571153Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
Q90999148Low Intensity Focused Ultrasound (LOFU)-mediated Acoustic Immune Priming and Ablative Radiation Therapy for in situ Tumor Vaccines
Q92463724Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
Q90608556Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity
Q99419129Opto-acoustic synergistic irradiation for vaporization of natural melanin-cored nanodroplets at safe energy levels and efficient sono-chemo-photothermal cancer therapy
Q47933732Phospholipid Capped Mesoporous Nanoparticles for Targeted High Intensity Focused Ultrasound Ablation.
Q37714274Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy
Q90146977The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models
Q47142549The use of 5-fluorouracil-loaded nanobubbles combined with low-frequency ultrasound to treat hepatocellular carcinoma in nude mice
Q89468280Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo
Q41548373Volumetric Optoacoustic Temperature Mapping in Photothermal Therapy.

Search more.